1.
Alwazzan A, Badeghiesh A, Almansouri M, et al. Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction. World J Oncol. 2026;17(5):676-682. doi:10.14740/wjon2800